SR 59230 is a β 3 - adrenergic receptor antagonist, and its four stereoisomers exhibit biological activity against different β-adrenergic receptor subtypes. SR 59230 partially inhibits lipolysis in rat adipocytes but shows no inhibitory effect on this process in human adipocytes, displaying species selectivity. SR 59230 can be used for studies on mechanisms related to β-adrenergic receptor subtypes.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Heart Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Adrenergic Receptor | Products > Signaling Pathways > Drug Intermediate
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.